ESR1 and breast carcinoma: It has been demonstrated that miR-221 and miR-222 each directly target ERα mRNA at a conserved site and are involved in anti-estrogen resistance.12,30–32 Our previous study also revealed that Notch3 trans-activated ERα and inhibited EMT and metastasis in breast cancer.23